Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Cash from Financing Activities: 2018-2025

Historic Cash from Financing Activities for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to $9.7 million.

  • Neurogene's Cash from Financing Activities rose 7312.21% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.8 million, marking a year-over-year increase of 126.30%. This contributed to the annual value of $184.1 million for FY2024, which is 99.03% up from last year.
  • Per Neurogene's latest filing, its Cash from Financing Activities stood at $9.7 million for Q3 2025, which was up 17,881.48% from $54,000 recorded in Q2 2025.
  • In the past 5 years, Neurogene's Cash from Financing Activities registered a high of $190.1 million during Q4 2024, and its lowest value of -$6.5 million during Q1 2024.
  • Its 3-year average for Cash from Financing Activities is $26.0 million, with a median of $107,000 in 2023.
  • In the last 5 years, Neurogene's Cash from Financing Activities crashed by 6,197.20% in 2024 and then spiked by 7,312.21% in 2025.
  • Over the past 3 years, Neurogene's Cash from Financing Activities (Quarterly) stood at $94.3 million in 2023, then surged by 101.56% to $190.1 million in 2024, then spiked by 7,312.21% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q3 2025, $54,000 for Q2 2025, and $4,000 during Q1 2025.